Multiple myeloma and Atrioventricular block first degree

Summary:

Atrioventricular block first degree is found among people with Multiple myeloma, especially for people who are male, 60+ old.

The study analyzes which people have Atrioventricular block first degree with Multiple myeloma. It is created by eHealthMe based on reports of 77 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,108 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

What is Atrioventricular block first degree?

Atrioventricular block first degree (heart block first degree) is found to be associated with 647 drugs and 890 conditions by eHealthMe. Check the latest studies of Atrioventricular block first degree.



On Jul, 20, 2026

77 people who have Multiple Myeloma and Atrioventricular Block First Degree are studied.

Would you have Atrioventricular block first degree when you have Multiple myeloma?

Gender of people who have Multiple Myeloma and experienced Atrioventricular Block First Degree *:

  • female: 29.73 %
  • male: 70.27 %

Age of people who have Multiple Myeloma and experienced Atrioventricular Block First Degree *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.49 %
  • 30-39: 1.49 %
  • 40-49: 2.99 %
  • 50-59: 13.43 %
  • 60+: 80.6 %

Common co-existing conditions for these people *:

  1. Dementia (madness): 6 people, 7.79%
  2. High Blood Pressure: 6 people, 7.79%
  3. Neuropathy Peripheral (surface nerve damage): 4 people, 5.19%
  4. Constipation: 4 people, 5.19%
  5. Nausea (feeling of having an urge to vomit): 4 people, 5.19%
  6. Indigestion: 3 people, 3.90%
  7. Allergic Rhinitis: 3 people, 3.90%
  8. Back Pain: 3 people, 3.90%
  9. Diabetes: 3 people, 3.90%
  10. Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 3.90%

Common drugs taken by these people *:

  1. Zometa: 24 people, 31.17%
  2. Aredia: 23 people, 29.87%
  3. Revlimid: 23 people, 29.87%
  4. Dexamethasone: 21 people, 27.27%
  5. Lyrica: 17 people, 22.08%
  6. Velcade: 17 people, 22.08%
  7. Compazine: 16 people, 20.78%
  8. Diflucan: 14 people, 18.18%
  9. Thalidomide: 12 people, 15.58%
  10. Melphalan: 11 people, 14.29%

Common symptoms for these people *:

  1. Nausea (feeling of having an urge to vomit): 27 people, 35.06%
  2. Bradycardia (abnormally slow heart action): 24 people, 31.17%
  3. Stress And Anxiety: 23 people, 29.87%
  4. Constipation: 22 people, 28.57%
  5. Nausea And Vomiting: 21 people, 27.27%
  6. Mitral Valve Incompetence (inefficient heart valve): 21 people, 27.27%
  7. Pain: 21 people, 27.27%
  8. Tricuspid Valve Incompetence (inefficient heart valve): 20 people, 25.97%
  9. Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 25.97%
  10. Weakness: 20 people, 25.97%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrioventricular block first degree?

- Check whether Atrioventricular block first degree is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Atrioventricular block first degree:

All the conditions that are associated with Atrioventricular block first degree:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrioventricular block first degree and Multiple myeloma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: